Viridian Therapeutics Inc (NASDAQ:VRDN)

17.91
Delayed Data
As of Oct 27
 +0.41 / +2.34%
Today’s Change
7.46
Today|||52-Week Range
25.67
+8.88%
Year-to-Date

Stock Price Forecast

The 7 analysts offering 12-month price forecasts for Viridian Therapeutics Inc have a median target of 38.00, with a high estimate of 44.00 and a low estimate of 28.00. The median estimate represents a +112.17% increase from the last price of 17.91.

Analyst Recommendations

The current consensus among 7 polled investment analysts is to Buy stock in Viridian Therapeutics Inc. This rating has held steady since October, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$1.25
Sales
$454.2K
Reporting Date
Nov 10

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 43.29%
 
 
 
 
 
 
Growthannually 82.74%
 
 
 
 
 
 

Sales

Growthquarterly -58.33%
 
 
 
 
 
 
Growthannually 224.13%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.